Skip to main content

Table 2 Basic characteristic, categorical variables

From: Comorbid status and the faecal microbial transplantation failure in treatment of recurrent Clostridioides difficile infection – pilot prospective observational cohort study

Variables

n = 60 (%)

Gender (male)

26 (43.33%)

Severe CDI

23 (38.33%)

Hospital-acquired infection

51 (85.00%)

History of 3 and more recurrences of CDI

11 (18.33%)

Diabetes mellitus type 2

13 (21.66%)

CCI ≥ 7

24 (40.00%)

Oncologic disease

11 (18.33%)

Dementia

10 (16.67%)

Chronic kidney disease

11 (18.33%)

Heart failure

22 (30.04%)

Liver disease, except cirrhosis

19 (31.67%)

Liver cirrhosis

2 (3.33%)

Myocardial infarction

10 (16.67%)

Arterial hypertension

43 (71.67%)

Stroke or TIA

10 (16.67%)

Hemiplegia

6 (10.00%)

Peptic ulcer

8 (13.33%)

Connective tissue disease

4 (6.67%)

COPD

9 (15.00%)

Peripheral artery disease

6 (10.00%)

AIDS

0 (0%)

HIV

1 (1.67%)

PPI therapy

25 (41.50%)

  1. AIDS acquired immunodeficiency syndrome, CCI Charlson Comorbidity Index, CDI Clostridium difficile infection, HIV human immunodeficiency virus, n number of subjects in cohort, PPI proton pump inhibitor, and TIA transient ischemic attack